Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Mar;113(3):636-641.
doi: 10.1016/j.fertnstert.2019.10.034.

Androgenicity and fertility treatment in women with unexplained infertility

Erica T Wang  1 , Michael P Diamond  2 , Ruben Alvero  3 , Peter Casson  4 , Gregory M Christman  5 , Christos Coutifaris  6 , Karl R Hansen  7 , Fangbai Sun  8 , Richard S Legro  9 , Randal D Robinson  10 , Rebecca S Usadi  11 , Margareta D Pisarska  12 , Nanette F Santoro  3 , Heping Zhang  8 ; National Institute of Child Health and Human Development (NICHD) Reproductive Medicine Network
Affiliations
Randomized Controlled Trial

Androgenicity and fertility treatment in women with unexplained infertility

Erica T Wang et al. Fertil Steril. 2020 Mar.

Abstract

Objective: To determine whether biochemical or clinical markers of androgenic activity predict live birth rate with ovarian stimulation in the unexplained infertility population.

Design: Secondary analysis of the Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation (AMIGOS) clinical trial.

Setting: Multicenter university-based clinical practices.

Patient(s): Nine hundred couples with unexplained infertility were included. Women were 18-40 years old with regular menses, a normal uterine cavity, at least one patent fallopian tube, and a male partner with ≥5 million motile sperm. Women were randomized to receive gonadotropin, clomiphene, or letrozole with IUI for four or fewer four treatment cycles. Women were evaluated for biochemical (total testosterone, DHEAS, and free androgen index) and clinical markers of androgenic activity (sebum, acne, and hirsutism). Multivariable logistic regression models adjusting for treatment group, maternal age, and body mass index were performed.

Intervention(s): None.

Main outcome measure(s): The primary outcome was live birth. Secondary outcomes included conception, clinical pregnancy, and pregnancy loss.

Result(s): When comparing 900 women in the AMIGOS trial based on quartiles of serum TT, women were of younger age, higher body mass index, and higher waist circumference with increasing TT. Increasing quartiles of TT also showed increasing DHEAS and free androgen index values. Serum androgens were not associated with outcomes of live birth, conception, clinical pregnancy, or pregnancy loss. Clinical androgen markers were not associated with pregnancy outcomes.

Conclusion(s): In a randomized cohort of women with unexplained infertility, biochemical and clinical measures of androgens did not predict live birth rate after ovarian stimulation treatment.

Clinical trial registration number: NCT 01044862.

Trial registration: ClinicalTrials.gov NCT01044862.

Keywords: Androgens; testosterone; unexplained infertility.

PubMed Disclaimer

References

    1. Vendola K, Zhou J, Wang J, Famuyiwa OA, Bievre M, Bondy CA. Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol Reprod 1999; 61:353–7. - PubMed
    1. Gervasio CG, Bernuci MP, Silva-de-Sa MF, Rosa ESAC. The role of androgen hormones in early follicular development. Obstet Gynecol 2014; 818010. - PMC - PubMed
    1. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998; 101:2622–9. - PMC - PubMed
    1. Weil S, Vendola K, Zhou J, Bondy CA. Androgen and follicle-stimulating hormone interactions in primate ovarian follicle development. J Clin Endocrinol Metab 1999; 84:2951–6. - PubMed
    1. Prizant H, Gleicher N, Sen A. Androgen actions in the ovary: balance is key. J Endocrinol 2014; 222:R141–51. - PubMed

Publication types

Associated data

LinkOut - more resources